Abstract:We report a novel series of chiral monometallic dithiocarbamate complexes with pendant phenolic groups, formulated as [M{κ2S^S-S2CN(CH2PhOH)(CH(S-CH3)(NaPh)}2] (M= Ni(II) S,S-1, Cu(II) S,S-2, Zn(II) S,S-3) and [M{κ2S^S-S2CN(CH2PhOH)(CH(R-CH3)(NaPh)}2] (M = Ni(II) R,R-4, Cu(II) R,R-5, Zn(II) R,R-6). These compounds were synthesized through a process involving chiral amino precursors S-HL1, R-HL2, CS2 and corresponding metal acetates. All the compounds have been characterized by microanalysis and standard spectroscopic methods such as 1H and 13C{1H}NMR, IR, UV-visible absorption and EPR spectroscopy. The spectral data suggest a square planar coordination geometry around the nickel(II) and copper(II) centers and a tetrahedral coordination geometry around the zinc(II) which is corroborated by density functional theory calculations. The unprecedented molecular structures of imine precursors S-I, R-I and Ni(II)-dithiocarbamate complex S,S-1 were elucidated by single crystal X-ray diffraction (SCXRD) and their crystal packing patterns were studied. Evidently, the change in chirality could not induce changes in the donor-acceptor sites of S-I and R-I and their molecules are primarily stabilized by O-H...N and C-H...π interactions, forming a 2D sheet-like structure in ab-plane. Notably, chiral S,S-1 complex crystallized in a monomeric achiral space group (triclinic, P1) in which two dithiocarbamate ligands are bonded to the nickel(II) ion in a S^S chelating mode forming a square planar geometry around the metal center. The photophysical properties of all the compounds have been investigated with the help of UV-visible absorption, emission, and thermogravimetric study. Compounds exhibited intense blue photoluminescence with maximum emissions in the 330-336 nm region upon excitation in the UV region. A molecular docking study was performed to validate the potentials of these compounds in protein-ligand interactions against B-DNA Dodecamer (PDB Id: 1BNA) and cyclins (PDB Id: 1w98) which are indeed essential proteins of the cell cycle, and their proper functioning is necessary for the human health.

Rhodium(III) complexes of 1-Alkyl-2-{(o-thioalkyl) phenylazo}imidazoles: synthesis, structure, spectral characterization, DNA binding study and DFT calculation

Synthesis, Characterization, Dna-Binding Studies of Rare Earth Complexes with N-Phenyl Norcantharidin Acylamide Acid

Synthesis, Characterization and DNA Binding of the Complexes of Rare Earth with Phenanthroline and Demethylcantharate

Rhodium(III) and iridium(III) complexes with 1,2-naphthoquinone-1-oximate as a bidentate ligand: synthesis, structure, and biological activity

Exploring an aggregation induced emission behaviour of neutral iridium complexes consisting of salicylaldimine ligand with dib enzosub erane core

Ruthenium, rhodium and iridium complexes containing diazafluorene derivative ligands: synthesis and biological studies

Synthesis and characterization of quinoxaline-based rhenium(I) organometallic compounds: Biological and computational applications

Synthesis, characterization, and DNA binding study of ruthenium(II/III) complexes containing ONS donor Schiff base

Antibacterial and ct-DNA binding studies of new synthesized ruthenium (III) hydroxamate complexes: Design, synthesis, DFT calculations and in-vitro study

Syntheses, Crystal Structures, and Photoluminescence of a Series of Iridium(III) Complexes Containing the Pentafluorosulfanyl Group

Synthetic, spectral and structural studies of ruthenium(II) compounds based on 2,6-diacetylpyridinemonoxime

Synthesis and biological evaluation of zwitterionic half-sandwich Rhodium(III) and Ruthenium(II) organometallic complexes

Synthesis, structural characterization, in vitro DNA binding, and antitumor activity properties of Ru(II) compounds containing 2(2,6-dimethoxypyridine-3-yl)-1H-imidazo(4,5-f)[1, 10]phenanthroline

Chiral Metal-dithiocarbamate Complexes Holding Pendant Phenolic Groups: Synthesis, Crystallographic, Photophysical and In-silico Study

Rhodium(I) Complexes Containing the N^N^N-Chelating Ligand: Synthesis, Structure, and Biological Activity

Synthesis, Characterization, and DNA‐Binding Properties of the Chiral Ruthenium(II) Complexes Δ‐ and Λ‐[Ru(bpy)2(dmppd)]2+ (dmppd = 10,12‐dimethylpteridino[6,7‐f] [1,10]phenanthroline‐11,13(10h,12h)‐dione; Bpy = 2,2′‐Bipyridine)

Synthesis and Properties of Three Tris(1,10-Phenanthroline) Ruthenium (ii) Derivatives

New Schiff's base derivative and their nano‐sized Cr (III), Fe (III), Ru (III), and Ir (III) complexes: Preparation, DFT, characterization, bio‐catalytic, DNA interactions, cytotoxicity, and docking studies

Nano-Crystallites of Ruthenium(III) Violurate Complex: Synthesis, Characterization, PXRD and DFT Structural Analysis. DNA/ HSA -Binding, Antiviral Activity Against COVID-19 and Molecular Docking Study

Novel metal(II) complexes with pyrimidine derivative ligand: synthesis, multi-spectroscopic, DNA binding/cleavage, molecular docking with DNA/BSA, and antimicrobial studies

Binuclear Ag(I) and Cu(I)- complexes supported by imidazo[1,2- α ]pyrimidine; synthesis, structure and DFT studies